Partnering
Partnering with CMC Pharma
Collaboration is at the heart of what we do. While providing a wide range of services, we build strategic partnerships that accelerate drug development, reduce risk, and deliver results. Whether you’re a start-up, a virtual biotech, an established pharmaceutical company, or even a fellow CDMO/CMO, partnering with CMC gives you access to our specialized expertise, integrated facilities, capacity, and end-to-end development capabilities.
Who We Partner With
- Our clients and collaborators include:
- Emerging Biotech and Start-Ups: Helping bring innovative therapies from concept to clinic with tailored, cost-effective development strategies.
- Established Pharmaceutical Companies: Supporting complex formulations, scale-up, and specialized analytical expertise.
- Device Companies: Developing analytical methods and formulations for evaluation in client devices: auto injectors, pre-filled syringes, drug-eluting stents and balloons, microneedle arrays and patches, and other drug delivery systems.
- Virtual Drug Development Companies: Providing a fully integrated team to fill gaps in capabilities, from formulation through cGMP labs and pilot production.
- CDMOs/CMOs and Industry Peers: Collaborating on specialized projects, leveraging our facilities for added bandwidth, analytical capabilities, and scientific expertise to achieve shared goals.
- Non-Profits and Government Programs: Over a decade experience as a prime and subcontractor assisting with CMC development and sound-data for regulatory submissions.
US Government Contracts
At CMC Pharmaceuticals, we are constantly exploring opportunities to collaborate. We actively seek partnerships with companies of all sizes and across all stages of development. Whether it’s co-developing a novel formulation, assisting a competitor CDMO with specialized capabilities, or supporting a new therapeutic platform, we are ready to bring our expertise, flexibility, and integrated approach to your program.
Since 2017, CMC Pharmaceuticals has been awarded over a dozen US government contracts as both a prime and subcontractor, primarily through the Department of Defense. Many of these programs focus on developing medical countermeasures to protect our service members from chemical threats.
Here are a few press releases that detail some of our recent programs:
- • $40M Contracted Awarded to Advance Medical Countermeasure Program
- • CMC Pharma Extends Shelf-life of Key Prophylactic, Receives FDA Approval
- • A Growing Nerve Agent Defense Portfolio
We have implemented specific company protocols and established the necessary infrastructure to comply with the US Government’s policies. Our accounting systems have been audited and are government-approved, and we are actively working toward CMMC Level 2 compliance.
Why Partner with CMC Pharmaceuticals?
| Problem | Solution |
|---|---|
| Multiple hand-offs between vendors slow development and increase risk. | CMC integrates formulation, analytical, and pilot-scale capabilities under one roof, streamlining timelines and reducing risk. |
| Gaps in technical expertise or regulatory support can stall programs. | Our team of scientists, regulatory experts, and development specialists provides end-to-end guidance tailored to your program. |
| High development costs from inefficiencies and repeated studies. | By providing a strategic, full-program view, we optimize resources, reduce redundant work, and de-risk your investment. |
| Internal capacity constraints can delay your program. | CMC’s flexible facilities and integrated services allow us to accommodate projects of all sizes, helping you stay on schedule without compromising quality. |
Send a message
Contact Us Today and find out how CMC Pharma can help you!
Whether you need to develop robust analytical methods or require routine testing, Contact CMC Pharma to learn how we can help you advance your development program.
Send us a message or give us a call at 440-485-1734